DELHI, India -- Molecular diagnostics is one of the segments of IVD market that identifies and analyzes nucleic acids (DNA or RNA) produced by the patient or by foreign organisms.It involves the use of genomic analysis techniques such as polymerase chain reaction (PCR), microarrays, and sequencing. Growth in this segment is driven by higher sensitivity, faster turnaround times, easier workflow, and lower costs (in some cases) than other techniques, such as immunoassays or conventional microbiology. Point of care diagnostics are defined as clinical tests that can be conveniently administered and quickly processed. Quick testing, early diagnosis of an infection and fast turn-around time are ensured by point of care diagnosis. Technological advancements are constantly being made in the IVD industry thereby increasing the robustness of these devices.
As per the report “Global IVD Market: 2014 Edition” by Koncept Analytics, the growth in IVD industry is driven by increasing ageing population and growing healthcare expenditure. Otherfactors providing a tailwind to the global IVD market is the rise of global diabetic population as well as rise of chronic and infectious diseases. The increase in the diabetic and other infectious diseases cases can be attributed to the ever changing lifestyle of the people in the present era. Nowadays people are more conscious towards health related issues and doctors prefer that the patients should undergo proper diagnosis before he/she takes any decision related to the treatment.
The IVD products are broadly divided into three categories: reagents, analytical instruments and accessory products. They are widely used for diagnosis, monitoring of prescribed treatments and assessment of medical intervention, apart from others thereby contributing to availability of medical information regarding a patient. Also, the demand for in-vitro diagnostics has been increased on account of changing lifestyle and rising consumer income level. Moreover, the market is poised to grow at a fast rate chiefly due to rising number of health problems particularly associated with aging people.
It also encompasses a number of factors encouraging the growth of the global IVD industry coupled with recent trends and challenges hindering the growth of the industry. The company profile section of the report covers detailed description of the players operating in the global IVD market along with in-depth analysis of regional competition among the major players. By deploying SPSS Inc.’s data integration and analysis capabilities, future growth prediction in terms of value of global IVD market has also been analyzed in the report.
List of Charts
IVD Market Segments by Technology Type
IVD Market by End Users
IVD Value Chain Analysis in Medical Application
Global In-Vitro Diagnostics Market (2009-2013)
IVD Market by Technology Type (2013)
IVD Market by Test Location (2013)
IVD Market by Disease Area (2013)
IVD Market by Products (2013)
Molecular Diagnostic Market Size (2011-2013)
Molecular Diagnostic Market by Technology Type (2013)
Molecular Diagnostic Market by Test Location (2013)
Molecular Diagnostic Market Therapeutic Area (2013)
IVD Market by Region (2013)
IVD Market of EU27+ EFTA (2009-2013)
IVD Market in Europe (2009-2013)
European IVD Market – by Countries (2013)
IVD Market Share in Europe – by Countries (2013)
IVD Market in China (2009-2013)
Domestic IVD Market of China (2013)
Global Health Care Expenditure Per Capita (2008-2013E)
Global Ageing Population (65 years and above) (2009-2013)
World Population with Diabetes, Age Group 20-79 years (2009-2013)
Global Gross National Income Per Capita (2009-2013)
MDx and Immunoassays Taking over Food Safety Testing Market
Global IVD Market – Share Breakdown by Company (2013)
Professional Diagnostic Market Share (2013)
HBGM Market Share (2013)
Conventional Microbiology Market Share (2013)
Flow Cytometry Market (2013)
Molecular Diagnostic Market Share (2013)
Abbott Laboratories Revenue Share by Business Unit (2013)
Abbott Laboratories Revenue and Net Income (2009-2013)
Siemens Revenue Share by Sectors (2014)
Siemens Revenue and Net Income (2010-2014)
Roche’s Revenue Share by Divisions (2013)
Roche’s Revenue and Net Income (2009-2013)
Sales of Johnson & Johnson’s by Business Segments (2013)
Revenues and Net Income of Johnson & Johnson (2010-2013)
Global In Vitro Diagnostics Market (2013-2017F)
List of Tables
IVD Market Key Players-by Segments
Country-wise Division of European IVD Market (2013)
Mergers and Acquisitions (2006-2014)
Global In-Vitro Diagnostic Sales of Market Players (2013-3Q14)
Reported Growth of IVD Players (2013-3Q14)
Ex-FX/ Organic Growth of IVD Players (2013-3Q14)
Dependent & Independent Variables (2009–2013)
Correlation Matrix
Model Summary – Coefficient of Determination
Regression Coefficients Output
Note: Purchase by Section Also Available
For more Information:
http://www.konceptanalytics.com/Researchreport/global-in-...
Koncept Analytics
Vikas Gupta
(Business Development Manager)
FFCS-36, Ansal Plaza
Vaishali, Ghaziabad
U.P - 201010
Tele: +91-120-4130959
Mobile: +91-9811715635
Mail ID – vikas@konceptanalytics.com
Contact
Vikas Gupta
+91-9811715635
vikas@konceptanalytics.com